Delcath Systems, Inc. is an interventional oncology company focused on treating cancers primary or metastatic to the liver. Its lead product, HEPZATO KIT (melphalan for Injection/Hepatic Delivery System), received FDA approval in August 2023 for uveal melanoma with unresectable hepatic metastases. In Europe, the device component is sold as CHEMOSAT Hepatic Delivery System for Melphalan. The company targets multiple liver cancer indications including uveal melanoma, colorectal, breast, neuroendocrine, pancreatic, cholangiocarcinoma, and hepatocellular carcinoma.
Q2 FY2026 — expected 2026-08-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001628280-26-012019 | EDGAR | 65K words |
| 2025-03-06 | 2024-12-31 | 0001628280-25-010797 | EDGAR | 62K words |
| 2024-03-26 | 2023-12-31 | 0001628280-24-013008 | EDGAR | 61K words |
| 2023-03-27 | 2022-12-31 | 0001193125-23-079836 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0001193125-22-090104 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001564590-21-016962 | EDGAR | — |
| 2020-03-25 | 2019-12-31 | 0001564590-20-012846 | EDGAR | — |
| 2019-06-14 | 2018-12-31 | 0001564590-19-022587 | EDGAR | — |
| 2018-03-16 | 2017-12-31 | 0001564590-18-005963 | EDGAR | — |
| 2017-03-29 | 2016-12-31 | 0001564590-17-005455 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001628280-26-053956 | EDGAR | 17K words |
| 2025-11-04 | 2025-09-30 | 0001628280-25-048558 | EDGAR | 19K words |
| 2025-08-06 | 2025-06-30 | 0001628280-25-038112 | EDGAR | 18K words |
| 2025-05-08 | 2025-03-31 | 0001628280-25-023507 | EDGAR | 14K words |
| 2024-11-08 | 2024-09-30 | 0001628280-24-046537 | EDGAR | 20K words |
| 2024-08-05 | 2024-06-30 | 0001628280-24-034769 | EDGAR | 18K words |
| 2024-05-14 | 2024-03-31 | 0001628280-24-023087 | EDGAR | 17K words |
| 2023-11-13 | 2023-09-30 | 0001628280-23-038618 | EDGAR | 39K words |
| 2023-08-09 | 2023-06-30 | 0001628280-23-028676 | EDGAR | 40K words |
| 2023-05-22 | 2023-03-31 | 0001193125-23-150523 | EDGAR | 23K words |
| 2022-11-08 | 2022-09-30 | 0001193125-22-280207 | EDGAR | — |
| 2022-08-08 | 2022-06-30 | 0001193125-22-215053 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-14 | 0001193125-26-350536 | EDGAR | 12K words |
| 2026-08-06 | 0001628280-26-053902 | EDGAR | 3K words |
| 2026-03-03 | 0001193125-26-088527 | EDGAR | 1K words |
| 2026-02-26 | 0001628280-26-012004 | EDGAR | 3K words |
| 2026-01-12 | 0001193125-26-010498 | EDGAR | 5K words |
| 2025-11-20 | 0001193125-25-289917 | EDGAR | 0K words |
| 2025-11-04 | 0001628280-25-048539 | EDGAR | 3K words |
| 2025-10-20 | 0001193125-25-242909 | EDGAR | 2K words |
| 2025-08-15 | 0001193125-25-181881 | EDGAR | 12K words |
| 2025-08-06 | 0001628280-25-038098 | EDGAR | 3K words |
449 total filings indexed. 417 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000872912 |
| Ticker | DCTH |
| Exchange | Nasdaq |
| SIC | 3841: Surgical & Medical Instruments & Apparatus |
| Incorporated | DE |
| Headquarters | Queensbury, New York |
| Website | https://www.delcath.com |
| Listed | 2000-10-19 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/DCTH (~200 tokens, structured JSON with cryptographic provenance)